Naunton K - Search Results

1

A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis.

Dahal S, Allette YM, Naunton K, Harrison DM. Dahal S, et al. Among authors: naunton k. Mult Scler Relat Disord. 2024 Jan;81:105344. doi: 10.1016/j.msard.2023.105344. Epub 2023 Nov 25. Mult Scler Relat Disord. 2024. PMID: 38035495 Free PMC article.

2

Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.

Harrison DM, Wang KY, Fiol J, Naunton K, Royal W 3rd, Hua J, Izbudak I. Harrison DM, et al. Among authors: naunton k. J Neuroimaging. 2017 Sep;27(5):461-468. doi: 10.1111/jon.12444. Epub 2017 May 2. J Neuroimaging. 2017. PMID: 28464368 Free PMC article.

3

Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis.

Royal W 3rd, Mia Y, Li H, Naunton K. Royal W 3rd, et al. Among authors: naunton k. J Neuroimmunol. 2009 Aug 18;213(1-2):135-41. doi: 10.1016/j.jneuroim.2009.05.012. Epub 2009 Jun 17. J Neuroimmunol. 2009. PMID: 19539379

4

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F; REGAIN Study Group. Siddiqi ZA, et al. Muscle Nerve. 2021 Dec;64(6):662-669. doi: 10.1002/mus.27422. Epub 2021 Oct 14. Muscle Nerve. 2021. PMID: 34590717 Clinical Trial.

5

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF Jr; REGAIN Study Group. Mantegazza R, et al. Neurology. 2021 Jan 26;96(4):e610-e618. doi: 10.1212/WNL.0000000000011207. Epub 2020 Nov 23. Neurology. 2021. PMID: 33229455 Free PMC article. Clinical Trial.

6

Consistent improvement with eculizumab across muscle groups in myasthenia gravis.

Mantegazza R, O'Brien FL, Yountz M, Howard JF Jr; REGAIN study group. Mantegazza R, et al. Ann Clin Transl Neurol. 2020 Aug;7(8):1327-1339. doi: 10.1002/acn3.51121. Epub 2020 Jul 22. Ann Clin Transl Neurol. 2020. PMID: 32700461 Free PMC article. Clinical Trial.

7

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF; REGAIN study group. Vissing J, et al. J Neurol. 2020 Jul;267(7):1991-2001. doi: 10.1007/s00415-020-09770-y. Epub 2020 Mar 18. J Neurol. 2020. PMID: 32189108 Free PMC article. Clinical Trial.

8

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.

Murai H, Uzawa A, Suzuki Y, Imai T, Shiraishi H, Suzuki H, Okumura M, O'Brien F, Wang JJ, Fujita KP, Utsugisawa K; REGAIN Study Group. Murai H, et al. J Neurol Sci. 2019 Dec 15;407:116419. doi: 10.1016/j.jns.2019.08.004. Epub 2019 Aug 3. J Neurol Sci. 2019. PMID: 31698177 Free article.

9

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr; REGAIN Study Group. Andersen H, et al. Qual Life Res. 2019 Aug;28(8):2255. doi: 10.1007/s11136-019-02204-x. Qual Life Res. 2019. PMID: 31115842 Free PMC article.

10

Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF Jr; REGAIN Study Group. Andersen H, et al. Qual Life Res. 2019 Aug;28(8):2247-2254. doi: 10.1007/s11136-019-02148-2. Epub 2019 Mar 23. Qual Life Res. 2019. PMID: 30905021 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters